Sulfoximines for Drug Design
Incorporation of sulfoximine group into bioactive compounds often improves their ADME/Tox profile, and enhances potency. Moreover, the moiety of sulfoximine is chemically and metabolically stable. NH-sulfoximines can serve as the both hydrogen bond donors and acceptors at the same time. Production and commercialization of the building blocks that already contain sulfoximine group allow significant accelerating discovery of drug candidates. Herein we have designed and synthesized a library of sulfoximines for drug design.
Design
- has high chemical and metabolical stability;
- increases aqueous solubility;
- serves as H-bond donor and acceptor.
Sulfoximine group:
We offer:
>100 unique sulfoximines on a 5-50 g scale from stock.
MedChem Highlights
- Silicon-Containing Building Blocks for Drug Design
- Epoxides for Drug Design
- Analogues of CF3-Pyridine for Drug Design
- Piperazine Bioisosteres for Drug Design
- Sugar-like Building Blocks for Drug Design
- Cyclic Sulfonamides for Drug Design
- Morpholine Bioisosteres for Drug Design
- P(O)Me2-containing Building Blocks for Drug Design
- Saturated Bioisosteres of ortho-/meta-substituted Benzenes
- Saturated bioisosteres of para-substituted benzenes
- Sulfonyl fluorides (-SO2F)
- Diazirines
- Oxetane-containing Building Blocks
- SF5-Building Blocks
- Stannanes for coupling reactions
- Sulfoximines for Drug Design
- Saturated Bioisosteres of Benzene
- Heterocyclic scaffolds
- Macrocycles
- Azide-linkers for Drug Design
- Unnatural Amino Acids
- Cubane-containing building blocks
- Benzoxaboroles for Drug Design